TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $60.4K2012: $15.0K2013: $725.0K2014: $1.06M2015: $2.29M2016: $4.00M2017: $7.26M2018: $1.14M2019: $589.0K2020: $229.0K2021: $809.0K2022: $512.0K2023: $1.01M2024: $182.0K2025: $0$0
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$0-100.0%
2024$182.0K-81.9%
2023$1.01M+96.9%
2022$512.0K-36.7%
2021$809.0K+253.3%
2020$229.0K-61.1%
2019$589.0K-48.2%
2018$1.14M-84.3%
2017$7.26M+81.8%
2016$4.00M+74.7%
2015$2.29M+116.6%
2014$1.06M+45.7%
2013$725.0K+4733.3%
2012$15.0K-75.2%
2011$60.4K—